Compare ICUI & INTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ICUI | INTA |
|---|---|---|
| Founded | 1984 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.3B |
| IPO Year | 1995 | 2021 |
| Metric | ICUI | INTA |
|---|---|---|
| Price | $165.97 | $47.11 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 9 |
| Target Price | ★ $193.38 | $41.57 |
| AVG Volume (30 Days) | 193.4K | ★ 505.8K |
| Earning Date | 11-05-2026 | 10-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 100.62 | N/A |
| EPS | ★ 1.96 | N/A |
| Revenue | ★ $2,231,262,000.00 | $577,805,000.00 |
| Revenue This Year | N/A | $14.07 |
| Revenue Next Year | $4.44 | $15.22 |
| P/E Ratio | $85.24 | ★ N/A |
| Revenue Growth | N/A | ★ 14.62 |
| 52 Week Low | $113.37 | $19.01 |
| 52 Week High | $192.85 | $48.19 |
| Indicator | ICUI | INTA |
|---|---|---|
| Relative Strength Index (RSI) | 55.69 | 75.59 |
| Support Level | $164.09 | $20.15 |
| Resistance Level | $167.67 | N/A |
| Average True Range (ATR) | 4.51 | 1.60 |
| MACD | 0.85 | 0.85 |
| Stochastic Oscillator | 86.13 | 91.26 |
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.
Intapp Inc is a provider of AI-powered solutions for professional firms in regulated industries. Its vertically tailored solutions are purpose-built for the specialized workflows, complex relationship networks, and professional compliance requirements of accounting, consulting, investment banking, legal, private capital, and real assets firms. By applying Firm AI to core processes and data, Intapp helps partners, dealmakers, and advisors drive firm growth, manage compliance, and improve profitability. Its products include AI & Data Platform, Intapp Celeste and Firm AI, and Intapp Integration Service. The Company operates in accounting, consulting, corporate, investment banking and advisory, and other industries. The Company operates in the UK and the US, with maximum revenue from the US.